In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Max Dordevic, Co-Founder & CEO at NeuroX1.

NeuroX1 is a company that utilises AI to identify and treat neurological diseases that affect millions of people every year. Max discusses how NeuroX1 brings their novel approach to the industry by working diligently to bring viable drug candidates into clinical trials sooner and reinvigorating the pipeline for drug targeting neurological and neuro-oncological diseases. Max provides insights into NeuroX1's approach of using AI and machine learning to accelerate drug discovery and development timelines.

In this episode you will learn:

How NeuroX1 uses AI for drug target identification
Their in silico preclinical testing approach
How they design novel drug candidates
Details on their current pharma clients and partnerships
What's next for scaling their AI-driven drug discovery work

For more information on NeuroX1 head to https://www.neurox1.com/

Click to connect with Dr. Andree Bates for more information in this episode: https://eularis.com/

AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business.

This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.

As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate qa1through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.

This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.

Resources:

Dr. Andree Bates LinkedIn | Facebook | Twitter

E84 | How to use AI to identify novel drivers of disease and then design novel molecules for those diseases in silico

AI For Pharma Growth

E84 | How to use AI to identify novel drivers of disease and then design novel molecules for those diseases in silico